GSTM1 and anemia: In the group of women with iron deficiency anemia, there was a statistically significant difference of all indicators of erythropoiesis (Hb, RBC, and HCT) and iron imbalance (CHr, HRC, RDW, and ferritin) after the therapy (p < 0.001) (Table 1).